References

• Bershad, A. K., Ruiz, N. A., & de Wit, H. (2018). Effects of buprenorphine on responses to emotional stimuli in individuals with a range of mood symptomatology. The International Journal of Neuropsychopharmacology, 21(2), 120–127. https://doi.org/10.1093/ijnp/pyx077
• Caritis, S. N., & Venkataramanan, R. (2020). Naltrexone use in pregnancy: A time for change. American Journal of Obstetrics and Gynecology, 222(1), 1–2. https://doi.org/10.1016/j.ajog.2019.08.041
• Herlinger, K., & Lingford‐Hughes, A. (2022). Opioid use disorder and the brain: A clinical perspective. Addiction, 117(2), 502–509. https://doi.org/10.1111/add.15636
• Hser, Y. I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course of opioid addiction. Harvard review of psychiatry, 23(2), 76–89. https://doi.org/10.1097/HRP.0000000000000052
• Teklezgi, B. G., Gjerde, H., & Mørland, J. (2019). Time-dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction. Addiction Biology, 24(3), 438–446. https://doi.org/10.1111/adb.12609